Rethink Medical Recognised as One of the Top 100 Startups of 2023 by the Association of Science and Technology Parks of Spain (APTE)

The Association of Science and Technology Parks of Spain (APTE) has unveiled its annual list of the top 100 startups of 2023, showcasing excellence and innovation in the emerging business landscape across its 51 science and technology parks in 15 Spanish autonomous communities.

Among the distinguished companies, Rethink Medical is proud to be acknowledged as one of the standout performers, not only ranking among the top 100 startups but also being one of the 32 startups led by women. This dual recognition underscores Rethink Medical's commitment to diversity and excellence in innovation.

The list compiled by APTE aims to highlight the quality and entrepreneurial capability thriving in Spain's science and technology parks. Rethink Medical, with its pioneering focus on innovation in medical devices through our revolutionary T-Control urinary catheter, has demonstrated exceptional growth potential and a significant contribution to the business landscape.

Moreover, the recognised startups will have the opportunity to showcase their innovations at the prestigious Transfiere Forum, taking place in Malaga from the 20th to the 22nd of March 2024. This event will provide Rethink Medical with a unique platform to present its advancements and establish valuable connections with industry leaders, investors, and other key stakeholders.

Rethink Medical extends gratitude to APTE for this honour and is committed to continuing to lead innovation in the field of medical device development, addressing the most pressing challenges in our society.